Dominant-negative effect of the c-fos family gene products on inducible NO synthase expression in macrophages

International Immunology

Volumn 15, Issue 11, 2003, Pages 1275-1282

  Okada, Seiji ^a,b   Obata, Shintaro ^a   Hatano, Masahiko ^a   Tokuhisa, Takeshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cellular activation; Monocyte macrophage; NO; Transcription factor

Indexed keywords

GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MACROPHAGE ACTIVATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, FOS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0242636431     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg126     Document Type: Article

References (39)

1. Lyons, C. R. 1995. The role of nitric oxide in inflammation. Adv. Immunol. 60:323.
2. MacMicking, J., Xie, Q.-W. and Nathan, C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
3. Moncada, S., Palmer, R. M. and Higgs, E. A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
4. Ding, A. H., Nathan, C. F. and Stuehr, D. J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
5. Pelletier, J. P., Jovanovic, D., Fernandes, J. C., Manning, P., Connor, J. R., Currie, M. G., Di Battista, J. A. and Martel-Pelletier, J. 1998. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum. 41:1275.
6. Singer, I. I., Kawka, D. W., Scott, S. J., Weidner, R., Mumford, R. A., Riehl, T. E. and Stenson, W. F. 1996. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871.
7. MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q. W., Sokol, K. and Hutchinson, N. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
8. L induced in activated macrophages. J. Immunol. 160:2590.
9. Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H. and Russell, S. W. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268:1908.
10. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W. and Murphy, W. J. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl Acad. Sci. USA 90:9730.
11. Xie, Q.-W., Whisnant, R. and Nathan, C. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779.
12. Dlaska, M. and Weiss, G. 1999. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase. J. Immunol. 162:6171.
13. Lopez-Collazo, E., Hortelano, S., Rojas, A. and Bosca, L. 1998. Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation. J. Immunol. 160:2889.
14. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N. and Kishimoto, T. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353.
15. Williams, S. C., Cantwell, C. A. and Johnson, P. F. 1991. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 5:1553.
16. Hu, H.-M., Baer, M., Williams, S. C., Johnson, P. F. and Schwartz, R. C. 1998. Redundancy of C/EBPα, -β, and -δ in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J. Immunol. 160:2334.
17. Angel, P. and Karin, M. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys Acta 1072:129.
18. Karin, M., Liu, Z. and Zandi, E. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
19. Piechaczyk, M. and Blanchard, J. M. 1994. c-fos proto-oncogene regulation and function. Crit. Rev. Oncol. Hematol. 17:93.
20. Hsu, W., Kerppola, T. K., Chen, P. L., Curran, T. and Chen-Kiang, S. 1994. Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. Cell. Biol. 14:268.
21. Okada, S., Fukuda, T., Inada, K. and Tokuhisa, T. 1999. Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells. Blood 93:816.
22. Bachiller, D. and Rüther, U. 1990. Inducible expression of the proto-oncogene c-fos in transgenic mice. Arch. Geschwulstforsh. 60:357.
23. Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C. and Thomas, M. 1983. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1910.
24. Xie, Q-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T. and Nathan, C. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
25. Kreipe, H., Radzun, H. J., Heidorn, K., Parwaresch, M. R., Verrier, B. and Muller, R. 1986. Lineage-specific expression of c-fos and c-fms in human hematopoietic cells: discrepancies with the in vitro differentiation of leukemia cells. Differentiation 33:56.
26. Inada, K., Okada, S., Phuchareon, J., Hatano, M., Sugimoto, T., Moriya, H. and Tokuhisa, T. 1998. c-Fos induces apoptosis in germinal center B cells. J. Immunol. 161:3853.
27. Kristof, A. S., Marks-Konczalik, J. and Moss, J. 2001. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 276:8445.
28. Ron, D. and Habener, J. F. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:439.
29. Economou, J. S., Rhoades, K., Essner, R., McBride, W, H., Gasson, J. C. and Morton, D. L. 1989. Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170:321.
30. Wedel, A., Sulski, G. and Ziegler-Heitbrock, H. W. 1996. CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 8:335.
31. Yao, J., Mackman, N., Edgington, T. S. and Fan, S. T. 1997. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J. Biol. Chem. 272:17795.
32. Liu, H., Sidiropoulos, P., Song, G., Pagliari, L. J., Birrer, M. J., Stein, B., Anrather, J. and Pope, R. M. 2000. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. J. Immunol. 164:4277.
33. Udalova, I. A., Night, C. J., Vidal, V., Nedospasov, S. A. and Kwiatkowski, D. 1998. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273:21178.
34. Kunsch, C., Lang, R. K., Rosen, C. A. and Shannon, M. F. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J. Immunol. 153:153.
35. LeClair, K. P., Blanar, M. A. and Sharp, P. A. 1992. The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc. Natl Acad. Sci. USA 89:8145.
36. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T. and Akira, S. 1993. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. USA 90:10193.
37. Plevy, S. E., Gemberling, H. J., Hsu, S., Dorner, A. J. and Smale, S. T. 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:4572.
38. Stein, B., Cogswell, P. C. and Baldwin, A. S. 1993. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:3964.
39. Zagariya, A., Mungre, S., Lovi, R., Birrer, M., Ness, S., Thimmapaya, B. and Pope, R. 1998. Tumor necrosis factor alpha gene regulation: enhancement of C/EBPbeta-induced activation by c-Jun. Mol. Cell. Biol. 18:2815.